产品详情 |
Edit |   |
Antigenic Specificity | CD22 |
Clone | Inotuzumab |
Host Species | n/a |
Reactive Species | human |
Isotype | n/a |
Format | calicheamicin drug conjugate |
Size | n/a |
Concentration | n/a |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC. This Antibody-Drug Conjugate (ADC) product is comprised of a Inotuzumab conjugated via a hydrazone linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Calicheamicin binds to DNA, causes DNA damage. |
Immunogen | n/a |
Other Names | n/a |
Gene, Accession # | Gene ID: 933, UniProt: P20273 |
Catalog # | ADC-W-338 |
Price | |
Order / More Info | CD22 Antibody from CREATIVE BIOLABS |
Product Specific References | n/a |
产品资料 |
|
|